Antara Capital LP
- SEC CIK
- 0001750183
- Latest filing
- Feb 17, 2026
TERN holding history
Terns Pharmaceuticals, Inc. in every 13F filed by Antara Capital LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TERN overviewAll 13F holders of TERNFull Q4 2025 holdings
- Shares (Q3 2022)
- 0
- Sold out in Q3 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | 0.0% | −874,600−100.0% | Sold out | Holders |
| Q2 2022 | 874,600 | $2.17M | 0.2% | −200,234−18.6% | Reduced | Holders |
| Q1 2022 | 1,074,834 | $3.19M | 0.2% | +125,000+13.2% | Added | Holders |
| Q4 2021 | 949,834 | $6.71M | 0.7% | +175,000+22.6% | Added | Holders |
| Q3 2021 | 774,834 | $8.07M | 1.6% | −1,100−0.1% | Reduced | Holders |
| Q2 2021 | 775,934 | $9.51M | 1.7% | +24,121+3.2% | Added | Holders |
| Q1 2021 | 751,813 | $16.3M | 4.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.